Clinical Trials Logo

Clinical Trial Summary

A good quality embryo and receptive endometrium are important aspects in achieving optimal outcomes in assisted reproductive treatment (ART). Endometrial thickness is an important marker of uterine receptivity. A thin endometrium defined by an endometrial thickness ≤7mm was reported as a poor factor associated with significantly lower implantation and pregnancy rates as well as a higher risk of miscarriage.

Nowadays, platelet-rich plasma (PRP) intrauterine infusion is a promising approach for the treatment of refractory thin endometrium in patients undergoing frozen-thawed embryo transfer. This is based on its ability to stimulate proliferation and angiogenesis with a large number of growth factors and cytokines i.e. the endometrium becomes thicker, with higher vascularity. PRP is easily prepared from an autologous blood sample that eliminates the risk of immunological reactions and transmission infections at low cost.

Endometrial blood flow is another important marker reflective of uterine receptivity. Although publications are increasing concerning the efficacy of PRP intrauterine infusion on endometrial expansion and proliferation in frozen-thawed embryo transfer cycles, yet its angiogenetic effects have not been evaluated so far in either thin endometrium or normal endometrium thickness.

Our study aims to evaluate endometrial and sub-endometrial vasculature patterns before and after PRP infusion in frozen-thawed embryo transfer cycles with normal endometrium thickness.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04247204
Study type Interventional
Source Mansoura University
Contact Hatem Abu Hashim, MD. FRCOG.PhD
Phone +20502300002
Email hatem_ah@hotmail.com
Status Not yet recruiting
Phase N/A
Start date February 8, 2020
Completion date October 5, 2020

See also
  Status Clinical Trial Phase
Completed NCT01668446 - Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles Phase 4
Terminated NCT04092829 - Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer N/A
Withdrawn NCT04954196 - Benefit of Amlodipine in HRT Cycle for Frozen Embryo Transfer in the Correction of Uterine Pulsatility Index Phase 2
Active, not recruiting NCT04758871 - Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles Phase 4
Completed NCT03740568 - Effect of Intervention on Progesterone Levels Before Euploid Embryo Transfer in Pregnancy Outcomes. N/A
Completed NCT04013438 - Luteal Phase Support During Frozen Embryo Transfer Cycle Phase 3
Recruiting NCT04371783 - A Randomized Trial Comparing the Live Birth Rate of Immediate Versus Delayed FET Following a Freeze-all Strategy N/A
Recruiting NCT03976544 - Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients Phase 4
Recruiting NCT04804020 - Natural Cycle vs. Modified Natural Cycle vs. Artificial Cycle Protocol for Endometrial Preparation. N/A
Completed NCT04837768 - Effect of Intramuscular Progesterone Supplementation on Clinical and Ongoing Pregnancy Rates in Patients With Low Serum Progesterone Levels on the Day of Embryo Transfer in Artificial Frozen Cycles N/A
Terminated NCT05802303 - Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation N/A
Recruiting NCT05716139 - Natural Cycle vs Programmed Cycle Frozen Embryo Transfer N/A
Enrolling by invitation NCT04455191 - Comparison of Thawing Embryos in Advance and on the Day of Transfer on Pregnancy Outcomes in FET Cycle N/A
Completed NCT03660007 - Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo Transfer
Recruiting NCT06307184 - Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer
Recruiting NCT05739019 - The Impact of Past Coronavirus Disease 19 (COVID-19) Infection on the Live Birth Rates of Frozen Embryo Transfer Cycles
Recruiting NCT06239376 - Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients N/A
Completed NCT01943812 - Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation Phase 4
Active, not recruiting NCT05555121 - Rescue Progesterone Supplementation During Frozen Embryo Transfer Phase 2
Withdrawn NCT05168865 - Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients. Phase 4